The Human Resources and Services Administration warned Johnson & Johnson Friday (Sept. 27) that it will be kicked out of the federal 340B drug discount program unless it commits by Monday to scrap its plan to replace upfront drug discounts with a new rebate approach, doubling down on an earlier warning to the company. HRSA also told J&J it would ask the HHS Office of Inspector General to take enforcement action if the drug maker doesn’t back down by the...